United Therapeutics (UTHR) Gross Profit (2009 - 2026)
United Therapeutics (UTHR) reported Gross Profit of $683.8 million for Q2 2026, down 3.8% from $711 million a year earlier but up 5.5% from the prior quarter.
Powered by 
Analysis
United Therapeutics (UTHR) Gross Profit (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, United Therapeutics' Gross Profit came in at $2.72 billion, down 0.8% year-over-year; for FY2025, it was $2.8 billion, up 9.0% from FY2024.
- Gross Profit has increased for six consecutive years, with a five-year compound annual growth rate of 15.3% (FY2020 to FY2025).
- By year, Gross Profit came in at $2.57 billion in FY2024 (+24.0%), $2.07 billion in FY2023 (+16.0%), $1.78 billion in FY2022 (+14.2%) and $1.56 billion in FY2021 (+13.7%).
- Five-year quarterly Gross Profit spans a low of $380.6 million in Q4 2021 and a high of $711 million in Q2 2025.
- Year over year, Gross Profit gained in six of the last eight quarters, with growth averaging 8.7%.
- The high point for year-over-year Gross Profit in five years was Q1 2024 (growth of 33.0%); the low point was Q1 2026 (a decline of 7.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $648.1 million (Q1 2026), $686.8 million (Q4 2025) and $698.6 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | United Therapeutics | 24.95 Bn | 15.14 Bn | 733.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 733.40 Mn |
| Jun 30, 2026 | 683.80 Mn |
| Mar 31, 2026 | 648.10 Mn |
| Dec 31, 2025 | 686.80 Mn |
| Sep 30, 2025 | 698.60 Mn |
| Jun 30, 2025 | 711.00 Mn |
| Mar 31, 2025 | 701.90 Mn |
| Dec 31, 2024 | 660.00 Mn |
| Sep 30, 2024 | 665.80 Mn |
| Jun 30, 2024 | 637.10 Mn |
| Mar 31, 2024 | 604.80 Mn |
| Dec 31, 2023 | 543.70 Mn |
| Sep 30, 2023 | 539.30 Mn |
| Jun 30, 2023 | 532.40 Mn |
| Mar 31, 2023 | 454.60 Mn |
| Dec 31, 2022 | 432.70 Mn |
| Sep 30, 2022 | 478.80 Mn |
| Jun 30, 2022 | 437.20 Mn |
| Mar 31, 2022 | 436.00 Mn |
| Dec 31, 2021 | 380.60 Mn |
API Access
United Therapeutics Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=UTHR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "UTHR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=UTHR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();